Mapp Biopharmaceutical Archives - Times of San Diego

Anti-ebola campaign

Tom York on Business: San Diego Biotech Working on Sudan Ebolavirus Treatment

by Tom York January 24, 2023January 25, 2023

Sorrento Valley biotech Mapp Biopharmaceutical is developing and manufacturing a monoclonal antibody treatment for Sudan ebolavirus

Tech

Ebola Drug ZMapp Enters First Clinical Trial

by Aleksandra Konstantinovic February 28, 2015February 28, 2015

Tech

Feds Working to Raise Production of ZMapp Ebola Drug

by Chris Jennewein October 1, 2014

Tech

Feds Make $42M Bet on Local Biotech to Develop Ebola Drug

by Chris Jennewein September 3, 2014September 3, 2014

Tech

Scripps Called Ground Central for Ebola Virus Researchers

by Chris Jennewein August 27, 2014August 27, 2014

Tech

Scripps to Host Panel on San Diego’s Effort to Battle Ebola Outbreak

by Alexander Nguyen August 26, 2014

Tech

Local Biotech’s Supplies of ZMapp Ebola Drug ‘Exhausted’

by Chris Jennewein August 13, 2014August 13, 2014

Local Biotech Increasing Production of ‘ZMapp’ Ebola Drug

by Chris Jennewein August 4, 2014

Tech

CNN: San Diego Biotech’s Drug Saved Ebola-Infected Americans

by Chris Jennewein August 4, 2014August 4, 2014